Vitamin A has anti-oligomerization effects on amyloid-β in vitro

Journal of Alzheimer's Disease

Volumn 27, Issue 2, 2011, Pages 271-280

  Takasaki, Junichi ^a   Ono, Kenjiro ^a   Yoshiike, Yuji ^b   Hirohata, Mie ^a   Ikeda, Tokuhei ^a   Morinaga, Akiyoshi ^a   Takashima, Akihiko ^b   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; amyloid ; oligomer; vitamin A

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ASCORBIC ACID; BETA CAROTENE; PYRIDOXINE; RETINAL; RETINOIC ACID; RETINOL; RIBOFLAVIN; THIOCTIC ACID; UBIDECARENONE; VITAMIN B GROUP;

ARTICLE; CYTOTOXICITY; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CROSS LINKING;

EID: 81855199775     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110455     Document Type: Article

References (36)

1. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. (Pubitemid 39061671)
2. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
3. Kirkitadze MD, Bitan G, Teplow DB (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J Neurosci Res 69, 567-577. (Pubitemid 34966869)
4. Walsh DM, Selkoe DJ (2007) Afj oligomers-a decade of discovery. J Neurochem 101, 1172-1184.
5. Fancy DA, Kodadek T (1999) Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci USA 96, 6020-6024. (Pubitemid 29256612)
6. Bitan G (2006) Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins. Methods Enzymol 413, 217-236. (Pubitemid 44528693)
7. Ono K, Condron MM, Ho L, Wang J, Zhao W, Pasinetti GM, Teplow DB (2008) Effects of grape seed-derived polyphenols on amyloid fj-protein self-assembly and cytotoxicity. J Biol Chem 283, 32176-32187.
8. Wang J, Ono K, Dickstein DL, Arrieta-Cruz I, Zhao W, Qian X, Lamparello A, Subnani R, Ferruzzi M, Pavlides C, Ho L, Hof PR, Teplow DB, Pasinetti GM (2010) Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. Neurobiol Aging, doi:10. 1016/j. neurobiolaging. 2010. 05. 004.
9. Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M (2011) Effects of sex hormones on Alzheimer's disease-associated fj-amyloid oligomer formation invitro. Exp Neurol 228, 298-302.
10. Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid fj-protein oligomers. Proc Natl Acad Sci USA 106, 14745-14750.
11. Ono K, Condron MM, Teplow DB (2010) Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid fj-protein assembly and toxicity. J Biol Chem285, 23186-23197.
12. Ono K, Yamada M (2011) Low-n oligomers as therapeutic targets of Alzheimer's disease. J Neurochem 117, 19-28.
13. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M (2004) Vitamin A exhibits potent antiamyloido-genic and fibril-destabilizing effects in vitro. Exp Neurol 189, 380-392. (Pubitemid 39221830)
14. Ono K, Hasegawa K, Naiki H, Yamada M (2005) Preformed fj-amyloid fibrils are destabilized by coenzyme Q10 in vitro. Biochem Biophys Res Commun 330, 111-116. (Pubitemid 40394942)
15. Ono K, Hirohata M, Yamada M (2006) a-lipoic acid exhibits anti-amyloidogenicity for fj-amyloid fibrils in vitro. Biochem Biophys Res Commun 341, 1046-1052. (Pubitemid 43221771)
16. Ronicke R, Klemm A, Meinhardt J, Schroder UH, Fandrich M, Reymann KG (2008) Afj mediated diminution of MTT reduction-an artefact of single cell culture? PLoS One 3, e3236.
17. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, Ohhashi Y, Ookoshi T, Ono K, Yamada M, Naiki H (2007) The anti-amyloidogenic effect is exerted against Alzheimer's fj-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 46, 1888-1899.
18. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid fj-protein (Afj) assembly: Afj40 and Afj42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100, 330-335. (Pubitemid 36078074)
19. Abe K, Saito H (1998) Amyloidfj protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci Res 31, 295-305. (Pubitemid 28446012)
20. Szuts EZ, Harosi FI (1991) Solubility of retinoids in water. Arch Biochem Biophys 287, 297-304.
21. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M (2001) Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30, 235-241. (Pubitemid 32684904)
22. Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT (1999) Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM 92, 39-45. (Pubitemid 29034099)
23. Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282. (Pubitemid 20015238)
24. Jimenez-Jimenez FJ, Molina JA, de Bustos F, Orti-Pareja M, Benito-Leon J, Tallon-Barranco A, Gasalla T, Porta J, Arenas J (1999) Serumlevels of fj-carotene, a-carotene and vitamin A in patients with Alzheimer's disease. Eur J Neurol 6, 495-497. (Pubitemid 29371150)
25. Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC (1992) Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 21, 91-94.
26. Goodman AB, Pardee AB (2003) Evidence for defective retinoid transport and function in late onset Alzheimer's disease. Proc Natl Acad Sci USA 100, 2901-2905. (Pubitemid 36297596)
27. Perrig WJ, Perrig P, Stahelin HB (1997) The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 45, 718-724. (Pubitemid 27248781)
28. Corcoran JP, So PL, Maden M (2004) Disruption of the retinoid signalling pathway causes a deposition of amyloid P in the adult rat brain. Eur J Neurosci 20, 896-902. (Pubitemid 39141297)
29. Ding Y, Qiao A, Wang Z, Goodwin JS, Lee ES, Block ML, Allsbrook M, McDonald MP, Fan GH (2008) Retinoic acid attenuates fj-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 28, 11622-11634.
30. Dev S, Adler AJ, Edwards RB (1993) Adult rabbit brain synthesizes retinoic acid. Brain Res 632, 325-328. (Pubitemid 24015534)
31. McCaffery P, Drager UC (1994) Hot spots of retinoic acid synthesis in the developing spinal cord. Proc Natl Acad Sci USA 91, 7194-7197. (Pubitemid 24226829)
32. Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier JM, Ruf-fenach F, Leroy P, Chambon P (1991) Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. EMBO J 10, 71-81. (Pubitemid 21905268)
33. Ahlemeyer B, Krieglstein J (2000) Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine- induced oxidative stress and apoptosis. Neurochem Int 36, 1-5. (Pubitemid 29481778)
34. Grundman M, Delaney P (2002) Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 61, 191-202. (Pubitemid 34665793)
35. Pardridge WM, Sakiyama R, Coty WA (1985) Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem 44, 1138-1141. (Pubitemid 15105766)
36. Werner EA, Deluca HF (2002) Retinoic acid is detected at relatively high levels in the CNS of adult rats. Am J Physiol Endocrinol Metab 282, E672-E678. (Pubitemid 34654785)